Page 441 - fbkCardioDiabetes_2017
P. 441

Cardiac Emergencies In Diabetes Mellitus                                 417





                 and improvements in CVD risk factors such as low-
                 ering  smoking  prevalence  and total cholesterol  and
                 blood  pressure  levels  have been  major  drivers  for
                 these improvements in CVD outcomes [14,]
                 Reference:
                 1.  Raz, P. W. Wilson, K. Strojek, Hyperglycemia and Diabetes in Myocardial
                   InfarctionDiabetes Care2009Mar;3233816
                 2.  Siegelaar SE, Kerr L, Jacober SJ. A Decrease in Glucose  Variability  Does
                   Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After
                   Acute Myocardial Infarction Diabetes Car e2001, 34:855-857,
                 3.  T. Thom, N. Haase, W. Rosamond, etal.the. for, Heart. American, Statis-
                   tics. Association, Committee, Statistics. Stroke, Subcommittee, Hypergly-
                   cemia and Diabetes  in Myocardial  Infarctionstics  Committee and Stroke
                   Statistics Subcommittee. Circulatione85e151.
                 4.  S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyörälä, M. Laakso, Hyperglyce-
                   mia and Diabetes in Myocardial InfarctionNEngl J Med. 1998339229234
                 5.  J. Stamler, O. Vaccaro, Wentworth.  D. Neaton,  other. Diabetes,  factors.
                   risk, cardiovascular. 12-yr, for. mortality, screened. men, the. in, Risk. Mul-
                   tiple, Intervention. Factor, Trial, Hyperglycemia and Diabetes in Myocardial
                   InfarctionDiabetes Care199316434444
                 6.  Kannel WB, McGee DL.Hyperglycemia and Diabetes in Myocardial Infarc-
                   tionDiabetes Care19792120126
                 7.  Cowie MR,  Mosterd A, Wood DA, et al. The epidemiology  of  HF. Eur
                   Heart J. 1997;18:208–25.
                 8.  Nichols  GA, Hiller  TA, Erbey  JR, Brown JB. Congestive  heart failure  in
                   type 2 diabetes:  prevalence,  incidence,  and risk factors. Diabetes  Care.
                   2001;24:1614–9.
                 9.  Delea TE, Edelsberg JS, Hagiwara M, Oster G, Phillips LS. Use of thiazo-
                   lidinediones  and  risk of heart failure in people  with type 2  diabetes: a
                   retrospective cohort study. Diabetes Care. 2003;26:2983–9.
                 10. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Fram-
                   ingham study. JAMA. 1979;241:2035–8.
                 11. Bertoni  AG, Tsai  A, Kasper  EK, Brancati FL. Diabetes  and idiopath-
                   ic  cardiomyopathy:  a nationwide  case-control  study. Diabetes  Care.
                   2003;26:2791–5.
                 12. Spooner  PM.  Sudden  cardiac  death:  influence  of  diabetes.  Diabetes
                   ObesMetab. 2008;10(7):523–32.
                 13.  El-Atat FA, McFarlane SI, Sowers JR, Bigger JT. Sudden cardiac death in
                   patients with diabetes. CurrDiab Rep. 2004;4(3):187–93.
                 14. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino RB, Sr, et al. Trends
                   in cardiovascular complications of diabetes. JAMA.2004;292(20):24959.





















                                                    Cardio Diabetes Medicine
   436   437   438   439   440   441   442   443   444   445   446